Shiladitya Sengupta
Guest Professor
Biological Engineering
Indian Institute of Technology Gandhinagar
India
Biography
Shiladitya Sengupta, PhD (University of Cambridge) is Guest Professor at Biological Engineering department. He is Assistant Professor at Harvard Medical School Brigham & Women's Hospital. His Research Interests include Understanding the basic relationships at the cellular level that define a pathological state.
Research Interest
Understanding the basic relationships at the cellular level that define a pathological state, Nanoparticles, physiologic neovascularization, drug carriers, nanotechnology, hepatocyte growth factor
Publications
-
Kulkarni A, Natarajan SK, Chandrasekar V, Pandey PR, Sengupta S. Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy. ACS Nano (2016) Sep 29.
-
Kulkarni AA, Vijaykumar VE, Natarajan SK, Sengupta S, Sabbisetti VS. Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer. Nanomedicine (2016) 12(7):1853-1861.
-
Calibasi Kocal G, Güven S, Foygel K, Goldman A, Chen P, Sengupta S, Paulmurugan R, Baskin Y, Demirci U. Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Sci. Rep. (2016) 6:38221. doi: 10.1038/srep38221.
